Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine

International Journal of Biomedical Science

Volumn 4, Issue 3, 2008, Pages 221-228

  Li, Ping ^a   Dai, Ya Ni ^a   Zhang, Jun Ping ^b   Wang, Ai Qin ^b   Wei, Qin ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Chitosan; Drug delivery system; Hydrogels; Nanoparticles; Nifedipine

Indexed keywords

ALGINIC ACID; BUFFER; CHITOSAN; NANOCARRIER; NIFEDIPINE; PHOSPHATE;

ARTICLE; CHEMICAL REACTION; COMPLEX FORMATION; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG RELEASE; DRUG STRUCTURE; DRUG UPTAKE; GASTROINTESTINAL TRACT; INFRARED SPECTROSCOPY; INTESTINE FLUID; PARTICLE SIZE; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIMULATION; TRANSMISSION ELECTRON MICROSCOPY; VALIDATION PROCESS;

EID: 72149113936     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. De S, Robinson D. Polymer relationships during preparation of chitosan-alginate and poly-L-lysine-alginate nanospheres. J Control Rel. 2003; 89: 101-112.
2. Sarmento B, Ribeiro AJ, Veiga F, Ferreira DC, Neufeld RJ. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J Nanosci Nanotechnol. 2007; 7:2833-2841.
3. Florence A. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual. Pharm Res. 1997; 14:259-266.
4. Shi J, Alves NM, Mano JF. Chitosan coated alginate beads containing poly(N-isopropylacrylamide) for dual-stimuli-responsive drug release. J Biomed Mater Res B Appl Biomater. 2008; 84(2):595-603.
5. Murata Y, Jinno D, Liu D, Isobe T, et al. The drug release profile from calcium-induced alginate gel beads coated with an alginate hydrolysate. Molecules. 2007; 12(11):2559-2566.
6. Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv Rev. 1998; 31: 267-285.
7. Smidsrod O, Skjakbraek G. Alginate as immobilization matrix for Cells. Trends Biotechnol. 1990; 8: 71-78.
8. Pan Y, Li YJ, Zhao HY, Zheng JM, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm. 2002; 249: 139-147.
9. Mladenovska K, Cruaud O, Richomme P, Belamie E, et al. 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int J Pharm. 2007; 345: 59-69.
10. Kotze AF, Thanou MM, Luebetaen HL, de Boer AG, et al. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco-2). J Pharm Sci. 1999; 88: 253-257.
11. Sarmento B, Ribeiro A, Veiga F, Sampaio P, et al. Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery. Pharm Res. 2007; 24(12): 2198-2206.
12. De Campos AM, Sanchez A, Alonso M J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001; 224: 159-168.
13. Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polymer Edn. 2005; 16(1): 43-56.
14. Xu YM, Du YM. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 2003; 250: 215-226.
15. Sarmento B, Ferreira DC, Jorgensen L, van de Weert M. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles. Eur J Pharm Biopharm. 2007; 65: 10-17.
16. Varon J. Treatment of Acute Severe Hypertension: Current and Newer Agents. Drugs. 2008; 68(3): 283-297
17. 2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007; 100(3): 342-353.
18. Li P, Zhang JP, Wang AQ. A Novel N-Succinylchitosan-graft-Polyacrylamide/Attapulgite Composite Hydrogel Prepared through Inverse Suspension Polymerization. Macromol Mater Eng. 2007; 292: 962-969.
19. Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. Swelling Characteristics and Drug Delivery Properties of Nifedipine-Loaded pH Sensitive Alginate-Chitosan Hydrogel Beads. J Biomed Mater Res B Appl Biomater. 2008; 00B: 000-000.
20. Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. A Novel pH Sensitive N-Siuccinyl Chitosan/Alginate Hydrogel Bead for Nifedipine Delivery. Biopharmaceutics & Drug Disposition. 2007; 29: 173-184.
21. Rajaonarivony M, Vauthier C, Couarraze G. Development of a new drug carrier made from alginate. J Pharm Sci. 1993; 82: 912-917
22. Ford J, Woolfe J, Florence AT. Nanospheres of cyclosporin A: poor oral absorption in dogs. Int J Pharm. 1999; 183: 3-6.
23. Li T, Shi XW, Du YM, Tang YF. Quaternized chitosan/alginate nanoparticles for protein delivery. J Biomed Mater Res A. 2007; 83(2): 383-390.
24. Gonzalez-Ferreiro M, Tillman L, Hardee G, Bodmeier R. Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carrier. Int J Pharm. 2002; 239: 47-59.
25. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm. 2007; 65: 215-232.
26. Chen SC, Wu YC, Mi FL, Lin YH, et al. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate crosslinked by genipin for protein drug delivery. J Control Rel. 2004; 96: 285-300.
27. Sartori C, Finch DS, Ralph B. Determination of the cation content of alginate thin films by FTIR spectroscopy. Polymer. 1997; 38: 43-51.
28. Xu XL, Fu Y, Hu HY, Duan YR, Zhang ZR. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 2006; 41: 266-273.
29. Sarmento B, Ribeiro A, Veiga F, Ferreira1 D. Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed Chromatogr. 2006; 20: 898-903.
30. Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. Protein immobilization in crosslinked alginate microparticles. J Microencapsul. 2002; 19: 37-44.
31. Vandenberg GW, De La Noue J. Evaluation of protein release from chitosan-alginate microcapsules produced using external or internal gelation. J Microencapsul. 2001; 18: 433-441.
32. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985; 60: 110-111.
33. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Rel. 1987; 5: 37-42.
34. Takka S, Ocak OH, Acartürk F. Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies. Eur J Pharm Biopharm. 1998; 6: 241-246.
35. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-157.
36. Yan XL, Khor E, Lim LY. Chitosan-alginate films prepared with chitosans of different molecular weights. J Biomed Mater Res. 2001; 58: 358-365.
37. Motwani SK, Chopra S, Talegaonkar S, Kohli K, et al. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterization. Eur J Pharm Biopharm. 2007; Articles in press.